Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma
This study is ongoing, but not recruiting participants.
Sponsor:
Threshold Pharmaceuticals
Information provided by:
Threshold Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00742963
First received: August 26, 2008
Last updated: August 3, 2011
Last verified: August 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2011 |
| Estimated Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |